Tg Therapeutics Stock Probability of Future Stock Price Finishing Under 18.57
| TGTX Stock | USD 16.30 0.59 3.49% |
Closest to current price TGTX long CALL Option Payoff at Expiration
TGTX |
TG Therapeutics Target Price Odds to finish below 18.57
The tendency of TGTX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 18.57 after 90 days |
| 16.30 | 90 days | 18.57 | about 98.0 |
Based on a normal probability distribution, the odds of TG Therapeutics to stay under $ 18.57 after 90 days from now is about 98.0 (This TG Therapeutics probability density function shows the probability of TGTX Stock to fall within a particular range of prices over 90 days) . Probability of TG Therapeutics price to stay between its current price of $ 16.30 and $ 18.57 at the end of the 90-day period is about 33.39 .
Given the investment horizon of 90 days TG Therapeutics has a beta of 0.57. This usually implies as returns on the market go up, TG Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding TG Therapeutics will be expected to be much smaller as well. Additionally TG Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. TG Therapeutics Price Density |
| Price |
Predictive Modules for TG Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TG Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TG Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TG Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. TG Therapeutics is not an exception. The market had few large corrections towards the TG Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TG Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TG Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.1 | |
β | Beta against NYSE Composite | 0.57 | |
σ | Overall volatility | 1.38 | |
Ir | Information ratio | -0.04 |
TG Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TG Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TG Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| TG Therapeutics generated a negative expected return over the last 90 days | |
| TG Therapeutics has high historical volatility and very poor performance | |
| TG Therapeutics currently holds about 195.71 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| TG Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 59.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Viking stock falls after Roche obesity data |
TG Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TGTX Stock often depends not only on the future outlook of the current and potential TG Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TG Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 148.5 M | |
| Cash And Short Term Investments | 217.5 M |
TG Therapeutics Technical Analysis
TG Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. TGTX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TG Therapeutics. In general, you should focus on analyzing TGTX Stock price patterns and their correlations with different microeconomic environments and drivers.
TG Therapeutics Predictive Forecast Models
TG Therapeutics' time-series forecasting models is one of many TG Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TG Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about TG Therapeutics
Checking the ongoing alerts about TG Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TG Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| TG Therapeutics generated a negative expected return over the last 90 days | |
| TG Therapeutics has high historical volatility and very poor performance | |
| TG Therapeutics currently holds about 195.71 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| TG Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 59.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Viking stock falls after Roche obesity data |
Check out TG Therapeutics Backtesting, TG Therapeutics Valuation, TG Therapeutics Correlation, TG Therapeutics Hype Analysis, TG Therapeutics Volatility, TG Therapeutics History as well as TG Therapeutics Performance. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for TGTX Stock analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is TG Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TG Therapeutics. If investors know TGTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TG Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.3 | Revenue Per Share 2.017 | Quarterly Revenue Growth 7.135 | Return On Assets 0.1059 | Return On Equity 0.4393 |
The market value of TG Therapeutics is measured differently than its book value, which is the value of TGTX that is recorded on the company's balance sheet. Investors also form their own opinion of TG Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is TG Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TG Therapeutics' market value can be influenced by many factors that don't directly affect TG Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TG Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TG Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TG Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.